Skip to main content
BMY logo
BMY
(NYSE)
Bristol-Myers Squibb Company
$61.51-- (--)
Loading... - Market loading

Bristol-Myers Squibb Company (BMY) Stock Price & Financial Analysis

Bristol-Myers Squibb Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$60.45 - $62.05
52-Week High$62.89
52-Week Low$42.52
Open$60.74
Volume7.60M
Average Volume (3M)12.01M
Market Cap125.91B
Shares Outstanding2.05B
P/E Ratio (TTM)17.30
Forward P/E12.85
Price to Sales (P/S)2.60
Price to Book (P/B)6.26
EV/EBITDA9.29
Revenue (TTM)48.48B
Net Income (TTM)7.28B
Free Cash Flow (TTM)11.91B
EPS (TTM)$3.57
Profit Margin15.01%
Operating Margin29.03%
Return on Equity (ROE)36.20%
Debt to Equity2.21
50-Day MA$57.34
200-Day MA$54.99
52-Week Change25.58%
Annual Dividend$2.51
Dividend Yield4.08%
Payout Ratio70.39%
Last Dividend Ex-DateJul 2, 2026

Frequently Asked Questions About Bristol-Myers Squibb Company

What is the current stock price for BMY?

As of the latest trading session, BMY stock trades at $61.51. The 52-week range is $42.52–$62.89, with a day range of $60.45–$62.05.

What is the P/E ratio for BMY?

Bristol-Myers Squibb Company's trailing P/E ratio is 17.3, meaning investors pay $17.3 for every $1 of annual earnings. The forward P/E is 12.8, reflecting analyst expectations for future earnings. Bristol-Myers Squibb Company operates in the Healthcare sector.

Does BMY pay dividends?

Yes, Bristol-Myers Squibb Company pays a 4.08% annual dividend yield ($2.51 per share). The payout ratio is 70.4%. The last ex-dividend date was 2026-07-02.

What do analysts recommend for BMY?

Based on 22 analysts, the consensus for BMY is Buy.

What is the market cap of BMY?

Bristol-Myers Squibb Company's market capitalization is $125.91B, classifying it as a large-cap company. Bristol-Myers Squibb Company operates in the Healthcare sector within the Drug Manufacturers - General industry.